Advertisement

European Countries in Science-Based Competition: The Case of Biotechnology

  • Margaret Sharp
Part of the British Association for the Advancement of Science book series

Abstract

The purpose of this chapter is to consider how best Europe can maximise its advantages in biotechnology. It is wrong to talk about biotechnology as an industry. It is not an industry but a technology, or rather a set of technologies. It is above all concerned with new approaches to old problems and new ways of doing things; it is a process technology, not a product technology. (This helps to explain why it has led to so few new products on the market some 15 years after it first emerged.) To maximise its advantage in biotechnology, Europe’s goal must be the rapid diffusion of the new process techniques. This chapter argues that the key to this diffusion process lies, not, as many would suggest, with the small firm sector, but with Europe’s major pharmaceutical and chemical companies. It further argues that the best way to promote the take-up of biotechnological processes lies in strong support for the science base, the building of bridging mechanisms between industry and academia, and a tough but sympathetic regulatory environment.

Keywords

Venture Capital Academic Science Biotechnology Firm Academic Sector Venture Capital Market 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. AABB (1988) Directory of British Biotechnology.Google Scholar
  2. ABRC/SPRU (1986) International Comparisons of Government Funding of Academic and Academically Related Research (obtainable in mimeo from SPRU, University of Sussex, Brighton, BN1 9RF, UK).Google Scholar
  3. Bull, A. T., G. Holt and M. Lilly (1982) Biotechnology: International Trends and Perspectives Paris: OECD.Google Scholar
  4. Coleman, R.F. (1987) ‘National Policies and Programmes in Biotechnology’. paper presented at Canada-OECD Joint workshop on National Policies and Priorities in Biotechnology, Toronto, Canada, 7–10 April. Reproduced in OECD (1988) Biotechnology: The Changing Role of Governemt Paris: OECD (1988).Google Scholar
  5. Dosi, G. (1982) ‘Technological Paradigms and Technological Trajectories: A Suggested Interpretation of the Determinants and Directions of Technical Change’, Research Policy, vol. 2, no. 3, pp 147–62.CrossRefGoogle Scholar
  6. Dosi, G. (1988) ‘The Nature of the Innovative Process’, Chapter 10 in G. Dosi, C. Freeman, R. Nelson, G. Silverberg, and L. Soete, (eds), Technical Change and Economic Theory (London: Frances Pinter).Google Scholar
  7. The Economist (1989) The Money Guzzling Genius of Biotechnology, 13 May, pp.91–2.Google Scholar
  8. Financial Times (1988) Supplement on Biotechnology, p.II ‘Ventures that may appeal to the heart of the City’, 28 May.Google Scholar
  9. Irvine, J., Martin, B. and Isard, P., (1990) Investing in the Future: An International Comparison of Government Support for Academic and Related Research (Aldershot: Edward Elgar).Google Scholar
  10. OTA (1984) Commercial Biotechnology: An International Analysis (US Congress Office of Technology Assessment, January).Google Scholar
  11. Raugel, P.J. (1986) ‘Specialised Biotechnology Firms Financed by Venture Capital’, Biofutur, special issue on Biotechnology in France, March.Google Scholar
  12. Sapienza, A. (1989). ‘Technology Transfer: An Assessment of the Major Institutional Vehicles for Diffusion’, Technovation, 9, Summer.Google Scholar
  13. Sharp, M. (1985) The New Biotechnology: European Governments in Search of a Strategy (Sussex European paper No 15: Science Policy Research Unit). (University of Sussex:)Google Scholar
  14. Tanaka, M. (1988) Industry-University Relations in the case of the new Biotechnology in Japan, mimeo, Saitama University. Tokyo, JapanGoogle Scholar
  15. Yuan, R. (1987) Biotechnology in Western Europe (US Department of Commerce: International Trade Administration, April).Google Scholar

Copyright information

© The British Association for the Advancement of Science 1991

Authors and Affiliations

  • Margaret Sharp

There are no affiliations available

Personalised recommendations